Penumbra took the TCT (Transcatheter Cardiovascular Therapeutics) by storm on Sunday with the results of its landmark STORM-PE randomized controlled trial. The Alameda, CA-based company reported that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback